Mechanisms of allergic reactions occurring during anaesthesia;Mécanismes immunologiques de l'allergie peranesthésique

Annales Francaises d'Anesthesie et de Reanimation

Volumn 30, Issue 3, 2011, Pages 240-245

  Magnan, A ^a   Pipet, A ^a   Berard F ^b   Malinovsky, J M ^c   Mertes, P M ^d  

^a UNIVERSITÉ DE NANTES   (France)

^b L INSTITUT DU THORAX   (France)

^c HÔPITAL MAISON BLANCHE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC REACTION; ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ARTICLE; DISEASE ACTIVITY;

EID: 79953158395     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.12.008     Document Type: Article

References (51)

1. Gruchalla R.S. Drug metabolism, danger signals, and drug-induced hypersensitivity. J Allergy Clin Immunol 2001, 108:475-488.
2. Adkinson N.F., Essayan D., Gruchalla R., Haggerty H., Kawabata T., Sandler J.D., et al. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol. 2002, 109:S461-S478.
3. Mertes P.M., Pinaud M. What are the physiopathological mechanisms? How can severe anaphylactoid reactions be explained?. Ann Fr Anesth Reanim 2002, (Suppl. 1):55s-72s.
4. Bohle B., Wagner B., Vollmann U., Buck D., Niggemann B., Szépfalusi Z., et al. Characterization of T cell responses to Hev b 3, an allergen associated with latex allergy in spina bifida patients. J Immunol. 2000, 164:4393-4398.
5. Sanderson J.P., Naisbitt D.J., Farrell J., Ashby C.A., Tucker M.J., Rieder M.J., et al. Sulfamethoxazole and its metabolite nitrososulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol. 2007, 178:5533-5542.
6. Rodriguez-Pena R., Lopez S., Mayorga C., Antunez C., Fernandez T.D., Torres M.J., et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol. 2006, 118:949-956.
7. Aubert N., Mertes P.M., Janaszak M., Moneret-Vautrin D.A., Laxenaire M.C., Kanny G., et al. Dendritic cells present neuromuscular blocking agent-related epitopes to T cells from allergic patients. Allergy. 2004, 59:1022-1023.
8. Pichler W.J. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol. 2002, 2:301-305.
9. Gerber B.O., Pichler W.J. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. AAPS J. 2006, 8:E160-E165.
10. Schmid D.A., Depta J.P., Lüthi M., Pichler W.J. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds. Mol Pharmacol. 2006, 70:356-365.
11. Birnbaum J., Vervloet D. Mechanisms of anaphylactic reactions to muscle relaxants: role of allergenic determinants. Monogr Allergy. 1992, 30:15-23.
12. Wu Y., Sanderson J.P., Farrell J., Drummond N.S., Hanson A., Bowkett E., et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol. 2006, 118:233-241.
13. Hertl M., Jugert F., Merk H.F. CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol. 1995, 132:215-220.
14. Zanni M.P., Mauri-Hellweg D., Brander C., Wendland T., Schnyder B., Frei E., et al. Characterization of lidocaine-specific T cells. J Immunol. 1997, 158:1139-1148.
15. Christiansen C. Late-onset allergy-like reactions to X-ray contrast media. Curr Opin Allergy Clin Immunol. 2002, 2:333-339.
16. Rozieres A., Hennino A., Rodet K., Gutowski M.C., Gunera-Saad N., Berard F., et al. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 2009, 64:534-542.
17. Cornejo-Garcia J.A., Fernandez T.D., Torres M.J., Carballo M., Hernan I., Antunez C., et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy. 2007, 62:1429-1438.
18. Strait R.T., Morris S.C., Smiley K., Urban J.F., Finkelman F.D. IL-4 exacerbates anaphylaxis. J Immunol. 2003, 170:3835-3842.
19. Hopkins J.E., Naisbitt D.J., Humphreys N., Dearman R.J., Kimber I., Park B.K. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells. Toxicology. 2005, 206:221-231.
20. Gaspard I., Guinnepain M.T., Laurent J., Bachot N., Kerdine S., Bertoglio J., et al. Il-4 and IFN-gamma mRNA induction in human peripheral lymphocytes specific for beta-lactam antibiotics in immediate or delayed hypersensitivity reactions. J Clin Immunol. 2000, 20:107-116.
21. Didier A., Cador D., Bongrand P., Furstoss R., Fourneron P., Senft M., et al. Role of the quaternary ammonium ion determinants in allergy to muscle relaxants. J Allergy Clin Immunol. 1987, 79:578-584.
22. Antúnez C., Fernández T., Blanca-Lopez N., Torres M.J., Mayorga C., Canto G., et al. IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response. Allergy. 2006, 61:940-946.
23. Batchelor F.R., Dewdney J.M., Gazzard D. Penicillin allergy: the formation of the penicilloyl determinant. Nature. 1965, 206:362-364.
24. Baldo B.A., Pham N.H., Zhao Z. Chemistry of drug allergenicity. Curr Opin Allergy Clin Immunol. 2001, 4:327-335.
25. Baldo B.A., Pham N.H. Structure-activity studies on drug-induced anaphylactic reactions. Chem Res Toxicol. 1994, 7:703-721.
26. Florvaag E., Johansson S.G., Oman H., Venemalm L., Degerbeck F., Dybendal T., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand. 2005, 49:437-444.
27. Laxenaire M.C., Mata-Bermejo E., Moneret-Vautrin D.A., Guéant J.L. Life-threatening anaphylactoid reactions to propofol (Diprivan). Anesthesiology. 1992, 7:275-280.
28. Aster R.H. Drug-induced immune cytopenias. Toxicology 2005, 209:149-153.
29. Andres E., Dali-Youcef N., Serraj K., Zimmer J. Recognition and management of drug-induced cytopenias: the example of idiosyncratic drug-induced thrombocytopenia. Expert Opin Drug Saf. 2009, 8:183-190.
30. Warkentin T.E., Greinacher A. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opin Drug Saf. 2009, 8:129-144.
31. Berthoux E. Maladie sérique à l'ofloxacine. Rev Fr Allerg Immunol Clin 2007, 47:418-420.
32. Stenton G.R., Vliagoftis H., Befus A.D. Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Ann Allergy Asthma Immunol. 1998, 81:1-11.
33. Marone G., Patella V., de Crescenzo G., Genovese A., Adt M. Human heart mast cells in anaphylaxis and cardiovascular disease. Int Arch Allergy Immunol. 1995, 107:72-75.
34. Bristow M.R., Ginsburg R., Harrison D.C. Histamine and the human heart: the other receptor system. Am J Cardiol. 1982, 49:249-251.
35. Vigorito C., Russo P., Picotti G.B., Chiariello M., Poto S., Marone G. Cardiovascular effects of histamine infusion in man. J Cardiovasc Pharmacol. 1983, 5:531-537.
36. Beaupre P.N., Roizen M.F., Cahalan M.K., Alpert R.A., Cassorla L., Schiller N.B. Hemodynamic and two-dimensional transesophageal echocardiographic analysis of an anaphylactic reaction in a human. Anesthesiology 1984, 60:482-484.
37. Nicolas F., Villers D., Blanloeil Y. Hemodynamic pattern in anaphylactic shock with cardiac arrest. Crit Care Med 1984, 12:144-145.
38. Silverman H.J., Van Hook C., Haponik E.F. Hemodynamic changes in human anaphylaxis. Am J Med 1984, 77:341-344.
39. Kapin M.A., Ferguson J.L. Hemodynamic and regional circulatory alterations in dog during anaphylactic challenge. Am J Physiol Heart Circ Physiol. 1985, 249:H430-H437.
40. Mink S., Becker A., Sharma S., Unruh H., Duke K., Kepron W. Role of autacoids in cardiovascular collapse in anaphylactic shock in anaesthetized dogs. Cardiovasc Res 1999, 43:173-182.
41. Morel D.R., Skoskiewicz M., Robinson D.R., Bloch K.J., Hoaglin D.C., Zapol W.M. Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep. Am J Physiol 1991, 261:H782-H792.
42. Morel D.R., Zapol W.M., Thomas S.J., Kitain E.M., Robinson D.R., Moss J., et al. C5a and thromboxane generation associated with pulmonary vasoand broncho-constriction during protamine reversal of heparin. Anesthesiology 1987, 66:597-604.
43. Austin S.M., Barooah B., Kim C.S. Reversible acute cardiac injury during cefoxitin-induced anaphylaxis in a patient with normal coronary arteries. Am J Med 1984, 77:729-732.
44. Druck M.N., Johnstone D.E., Staniloff H., McLaughlin P.R. Coronary artery spasm as a manifestation of anaphylactoid reaction to iodinated contrast material. Can Med Assoc J 1981, 125:1133-1135.
45. Levine H.D. Acute myocardial infarction following wasp sting. Report of two cases and critical survey of the literature. Am Heart J 1976, 91:365-374.
46. Wagdi P., Mehan V.K., Burgi H., Salzmann C. Acute myocardial infarction after wasp stings in a patient with normal coronary arteries. Am Heart J 1994, 128:820-823.
47. Dewachter P., Jouan-Hureaux V., Franck P., et al. Anaphylactic shock: a form of distributive shock without inhibition of oxygen consumption. Anesthesiology 2005, 103:40-49.
48. Jacobs R.L., Rake G.W., Fournier D.C., Chilton R.J., Culver W.G., Beckmann C.H. Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. J Allergy Clin Immunol 1981, 68:125-127.
49. Laxenaire M.C., Torrens J., Moneret-Vautrin D.A. Choc anaphylactoïde mortel chez un malade traité par bétabloquants. Ann Fr Anesth Reanim. 1984, 3:453-455.
50. Zaloga G.P., DeLacey W., Holmboe E., Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med. 1986, 105:65-66.
51. Javeed N., Javeed H., Javeed S., Moussa G., Wong P., Rezai F. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn. 1996, 39:383-384.